1. Home
  2. RCKT vs ALEX Comparison

RCKT vs ALEX Comparison

Compare RCKT & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • ALEX
  • Stock Information
  • Founded
  • RCKT 1999
  • ALEX 1870
  • Country
  • RCKT United States
  • ALEX United States
  • Employees
  • RCKT N/A
  • ALEX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • ALEX Real Estate Investment Trusts
  • Sector
  • RCKT Health Care
  • ALEX Real Estate
  • Exchange
  • RCKT Nasdaq
  • ALEX Nasdaq
  • Market Cap
  • RCKT 1.1B
  • ALEX 1.3B
  • IPO Year
  • RCKT N/A
  • ALEX N/A
  • Fundamental
  • Price
  • RCKT $10.47
  • ALEX $17.61
  • Analyst Decision
  • RCKT Strong Buy
  • ALEX Buy
  • Analyst Count
  • RCKT 10
  • ALEX 3
  • Target Price
  • RCKT $48.80
  • ALEX $22.50
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • ALEX 254.9K
  • Earning Date
  • RCKT 03-04-2025
  • ALEX 02-27-2025
  • Dividend Yield
  • RCKT N/A
  • ALEX 5.11%
  • EPS Growth
  • RCKT N/A
  • ALEX N/A
  • EPS
  • RCKT N/A
  • ALEX 0.61
  • Revenue
  • RCKT N/A
  • ALEX $230,949,000.00
  • Revenue This Year
  • RCKT N/A
  • ALEX N/A
  • Revenue Next Year
  • RCKT $225,168.40
  • ALEX N/A
  • P/E Ratio
  • RCKT N/A
  • ALEX $21.48
  • Revenue Growth
  • RCKT N/A
  • ALEX 1.30
  • 52 Week Low
  • RCKT $9.33
  • ALEX $15.53
  • 52 Week High
  • RCKT $31.47
  • ALEX $20.30
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.20
  • ALEX 43.41
  • Support Level
  • RCKT $9.33
  • ALEX $17.48
  • Resistance Level
  • RCKT $11.09
  • ALEX $18.09
  • Average True Range (ATR)
  • RCKT 0.52
  • ALEX 0.24
  • MACD
  • RCKT 0.11
  • ALEX -0.02
  • Stochastic Oscillator
  • RCKT 53.77
  • ALEX 21.31

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc operates in the real estate sector. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces and also urban ground leases in Hawaii, thereby accounting for majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Share on Social Networks: